Study finds antidepressant helps relieve pain from chemotherapy
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful numbness and tingling feelings caused by chemotherapy in 59 percent of patients, a new study led by University of Michigan Comprehensive Cancer Center researchers finds. This is the first clinical trial to find an effective treatment for this pain. Other NCI-designated Cancer Centers or host universities involved in the study were: Duke University, Memorial Sloan-Kettering Cancer Center, Dartmouth-Hitchcock Medical Center, and Ohio State University.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.